nsv4761695
- Organism: Homo sapiens
- Study:nstd199 (Quan et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:20,163
- Publication(s):Quan et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 462 SVs from 40 studies. See in: genome view
Overlapping variant regions from other studies: 463 SVs from 41 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nsv4761695 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 46,951,226 | 46,971,388 |
nsv4761695 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 46,810,661 | 46,830,781 |
Variant Call Information
Variant Call ID | Type | Method | Analysis |
---|---|---|---|
nssv16296222 | inversion | Sequencing | Split read mapping |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nssv16296222 | Remapped | Good | NC_000023.11:g.469 51226_46971388inv | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 46,951,226 | 46,971,388 |
nssv16296222 | Submitted genomic | NC_000023.10:g.468 10661_46830781inv | GRCh37 (hg19) | NC_000023.10 | ChrX | 46,810,661 | 46,830,781 |